TransMedics Group, Inc.

NasdaqGM:TMDX

Market Cap

USD 4.40 B

Share Price

USD 130.06

Avg Daily Volume

1,053,661

Change (1 day)

1.15%

Change (1 year)

-10.09%

Change (YTD)

108.60%

TransMedics Group, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2025: USD 14.59

TransMedics Group, Inc. Revenue Per Share is USD 14.59 for the Trailing 12 Months (TTM) ending March 31, 2025, a 60.36% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • TransMedics Group, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 9.10, a 133.81% change year over year.
  • TransMedics Group, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 3.89, a 175.92% change year over year.
  • TransMedics Group, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 1.41, a 47.13% change year over year.
  • TransMedics Group, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 0.96, a -30.58% change year over year.
Key data
Date Revenue Per Share Free Cash Flow Per Share Dividend Per Share Debt to Equity Ratio
Market news
Loading...
NasdaqGM: TMDX

TransMedics Group, Inc.

CEO Dr. Waleed H. Hassanein M.D.
IPO Date May 2, 2019
Location United States
Headquarters 200 Minuteman Road
Employees 728
Sector 🏥 Health Care
Industries
Description

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Similar companies

SHL.DE

Siemens Healthineers AG

USD 54.80

0.08%

4543.T

Terumo Corporation

USD 18.68

0.63%

BAX

Baxter International Inc.

USD 30.50

-0.36%

RGC

Regencell Bioscience Holdings Limited

USD 20.19

-7.09%

600010.SS

Inner Mongolia Baotou Steel Union Co., Ltd.

USD 0.25

1.67%

CTEC.L

ConvaTec Group Plc

USD 3.97

0.12%

300832.SZ

Shenzhen New Industries Biomedical Engineering Co., Ltd.

USD 7.86

-1.68%

688617.SS

APT Medical Inc.

USD 41.08

1.04%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 4.54

-0.25%

SOL.MI

SOL S.p.A.

USD 54.81

1.44%

MCOV-B.ST

Medicover AB (publ)

USD 25.83

0.42%

600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd.

USD 4.04

2.16%

LALPATHLAB.NS

Dr. Lal PathLabs Limited

USD 32.08

-0.27%

0853.HK

MicroPort Scientific Corporation

USD 1.11

1.19%

NVCR

NovoCure Limited

USD 17.10

-1.33%

QDEL

QuidelOrtho Corporation

USD 28.70

2.10%

603882.SS

Guangzhou Kingmed Diagnostics Group Co., Ltd.

USD 4.09

3.84%

603567.SS

Heilongjiang ZBD Pharmaceutical Co., Ltd.

USD 1.66

-0.44%

300026.SZ

Tianjin Chase Sun Pharmaceutical Co.,Ltd

USD 0.52

0.52%

688016.SS

Shanghai MicroPort Endovascular MedTech Co., Ltd.

USD 12.27

0.36%

UNH

UnitedHealth Group Incorporated

USD 302.62

0.20%

MRK

Merck & Co., Inc.

USD 78.83

-1.05%

ISRG

Intuitive Surgical, Inc.

USD 534.19

2.41%

BSX

Boston Scientific Corporation

USD 104.58

0.28%

SYK

Stryker Corporation

USD 390.40

-0.47%

MCK

McKesson Corporation

USD 722.00

0.50%

ELV

Elevance Health Inc.

USD 373.18

-0.18%

CI

Cigna Corporation

USD 330.00

4.43%

CPG.L

Compass Group PLC

USD 33.72

0.24%

COR

Cencora, Inc.

USD 296.58

1.46%

207940.KS

Samsung Biologics Co.,Ltd.

USD 733.27

-0.09%

CAH

Cardinal Health, Inc.

USD 165.61

1.14%

RMD

ResMed Inc.

USD 256.21

-0.66%

GEHC

GE HealthCare Technologies Inc.

USD 74.86

2.90%

HUM

Humana Inc.

USD 239.90

0.58%

FRE.DE

Fresenius SE & Co. KGaA

USD 49.36

0.93%

IQV

IQVIA Holdings Inc.

USD 158.16

-0.35%

CNC

Centene Corporation

USD 53.57

0.11%

4013.SR

Dr. Sulaiman Al Habib Medical Services Group Company

USD 70.60

1.53%

NTRA

Natera, Inc.

USD 168.17

2.44%

PHIA.AS

Koninklijke Philips N.V.

USD 24.01

0.50%

LH

Laboratory Corporation of America Holdings

USD 256.98

-0.66%

PME.AX

Pro Medicus Limited

USD 184.38

1.43%

ZBH

Zimmer Biomet Holdings, Inc.

USD 91.74

-1.13%

6618.HK

JD Health International Inc.

USD 5.50

1.80%

BIM.PA

bioMérieux S.A.

USD 140.05

0.52%

300015.SZ

Aier Eye Hospital Group Co., Ltd.

USD 1.74

0.62%

FME.DE

Fresenius Medical Care AG & Co. KGaA

USD 56.22

1.54%

MOH

Molina Healthcare, Inc.

USD 291.06

-1.05%

9735.T

SECOM Co., Ltd.

USD 35.68

-0.52%

StockViz Staff

June 27, 2025

Any question? Send us an email